Location

Suwanee, GA

Start Date

7-5-2024 1:00 PM

End Date

7-5-2024 4:00 PM

Description

Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri or benign intracranial hypertension, is a neurological condition characterized by elevated intracranial pressure, leading to headache, tinnitus, and transient visual loss. There is currently no clearly outlined pathophysiology; however, IIH predominantly impacts reproductive-aged women who are overweight or obese. The prevalence of IIH is estimated to be approximately 1 in 100,000 individuals. In young females with obesity, the rate increases to 20 out of every 100,000. Beyond its neurological implications, IIH can give rise to psychiatric manifestations over time. The initial presentation of IIH, especially for those experiencing it for the first time, can be distressing and traumatic. The psychological repercussions of an IIH diagnosis and its subsequent treatment can be detrimental, often leading to depression and anxiety in affected individuals. Since IIH is uncommon, and also has an unknown pathophysiology, management can be challenging beyond the pharmacologic treatment modality of headache medications and diuretics.

Historically, patients have been advised to pursue weight loss and maintain regular follow-ups with their primary care physicians (PCPs), ophthalmologists, and neurologists to mitigate the frequency of episodes. However, a more inclusive and holistic approach to IIH management is crucial. It is imperative to recognize that each patient is unique and should not be reduced to a statistical consideration. Effective IIH management requires a comprehensive care team to ensure that the patient feels supported in all aspects of health management. This approach should have a PCP serving as the center of a coordinated care model encompassing various resources (e.g., mental health professionals, dietitians, osteopathic manipulative treatment.) Emphasizing the importance of a holistic strategy that addresses both mental and physical aspects of the disease can improve positive outcomes in patient care and disease management. Until further research sheds light on the underlying pathophysiology of IIH, the focus should shift towards establishing holistic treatment protocols and developing multifaceted care teams to promote the best outcomes for patients. This approach will empower patients and allow them to foster a sense of control in the face of this challenging condition.

Embargo Period

7-26-2024

COinS
 
May 7th, 1:00 PM May 7th, 4:00 PM

A holistic approach to idiopathic intracranial hypertension treatment and management

Suwanee, GA

Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri or benign intracranial hypertension, is a neurological condition characterized by elevated intracranial pressure, leading to headache, tinnitus, and transient visual loss. There is currently no clearly outlined pathophysiology; however, IIH predominantly impacts reproductive-aged women who are overweight or obese. The prevalence of IIH is estimated to be approximately 1 in 100,000 individuals. In young females with obesity, the rate increases to 20 out of every 100,000. Beyond its neurological implications, IIH can give rise to psychiatric manifestations over time. The initial presentation of IIH, especially for those experiencing it for the first time, can be distressing and traumatic. The psychological repercussions of an IIH diagnosis and its subsequent treatment can be detrimental, often leading to depression and anxiety in affected individuals. Since IIH is uncommon, and also has an unknown pathophysiology, management can be challenging beyond the pharmacologic treatment modality of headache medications and diuretics.

Historically, patients have been advised to pursue weight loss and maintain regular follow-ups with their primary care physicians (PCPs), ophthalmologists, and neurologists to mitigate the frequency of episodes. However, a more inclusive and holistic approach to IIH management is crucial. It is imperative to recognize that each patient is unique and should not be reduced to a statistical consideration. Effective IIH management requires a comprehensive care team to ensure that the patient feels supported in all aspects of health management. This approach should have a PCP serving as the center of a coordinated care model encompassing various resources (e.g., mental health professionals, dietitians, osteopathic manipulative treatment.) Emphasizing the importance of a holistic strategy that addresses both mental and physical aspects of the disease can improve positive outcomes in patient care and disease management. Until further research sheds light on the underlying pathophysiology of IIH, the focus should shift towards establishing holistic treatment protocols and developing multifaceted care teams to promote the best outcomes for patients. This approach will empower patients and allow them to foster a sense of control in the face of this challenging condition.